The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Amyloidosis in Alzheimer’s Disease: Pathogeny, Etiology, and Related Therapeutic Directions
Open accessAbstract
The amyloid hypothesis of Alzheimer’s disease has long been the predominant theory, suggesting that Alzheimer’s disease is caused by the accumulation of amyloid beta protein (Aβ) in the brain, leading to neuronal toxicity in the central nervous system (CNS). Because of breakthroughs in molecular medicine, the amyloid pathway is thought to be central to the pathophysiology of Alzheimer’s disease (AD). Currently, it is believed that altered biochemistry of the Aβ cycle remains a central biological feature of AD and is a promising target for treatment. This review provides an overview of the process of amyloid formation, explaining the transition from amyloid precursor protein to amyloid beta protein. Moreover, we also reveal the relationship between autophagy, cerebral blood flow, ACHE, expression of LRP1, and amyloidosis. In addition, we discuss the detailed pathogenesis of amyloidosis, including oxidative damage, tau protein, NFTs, and neuronal damage. Finally, we list some ways to treat AD in terms of decreasing the accumulation of Aβ in the brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The amyloid hypothesis emphasizes that the accumulation of Aβ plaques in the brain is a central event in the pathogenesis of AD, leading to neurodegeneration and cognitive decline.”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [11]
In the citing paper
“The hydrophobic C-terminus of Aβ42 facilitates its aggregation and the formation of senile plaques.”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [11]
In the citing paper
“Aβ originates from the processing of the amyloid precursor protein (APP) through sequential cleavage by β-secretase and γ-secretase, resulting in various lengths of Aβ fragments, with Aβ40 and Aβ42 being predominant.”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [11]
In the citing paper
“However, the relationship between FAD mutations and Aβ levels is complex, and the plaque formation in sporadic AD is influenced by a dynamic imbalance between Aβ production and clearance mechanisms [11,12].”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [11]
In the citing paper
“Mutations in presenilin-1 (PS1) can promote Aβ accumulation through increased production and impaired autophagy functions.”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Maiti, P., Bowers, Z., Bourcier, A., Morse, J., & Dunbar, G. L. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00769-9 · Cited by 44
RetractedNIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Forecasting the global burden of Alzheimer's disease
Brookmeyer, R., Johnson, E., Ziegler‐Graham, K., & Arrighi, H. M. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.04.381 · Cited by 3,370
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 243
Gutiérrez, R. M. P., Gómez, J. T., Flores, J. M. M., Téllez, M. D. L. L. C., & Muñiz-Ramírez, A. (2025) · Pharmaceuticals · doi:10.3390/ph18091391 · Cited by 5
Gu, W., Cong, X., Pei, Y., Ajuyo, N. M. C., Min, Y., & Wang, D. (2024) · Metabolites · doi:10.3390/metabo14070369 · Cited by 4
Zyuz’kov, G. N., Miroshnichenko, L. A., Polyakova, T. Y., Simanina, E. V., & Chaikovskii, A. V. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249302264240715060630 · Cited by 4
Ju, I. G., Lee, J. H., Lee, J. M., Im, H., Eo, H., Moon, M., Song, M. K., Kim, Y.-S., Oh, M. S., & Kim, Y.-J. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.11.008 · Cited by 4
Plasmalogens Improve Lymphatic Clearance of Amyloid Beta from Mouse Brain and Cognitive Functions
Shirokov, A. A., Zlatogosrkaya, D., Adushkina, V., Vodovozova, E. L., Kardashevskaya, K., Sultanov, R. M., Kasyanov, S. P., Blokhina, I., Terskov, A. V., Tsoy, M. O., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312552 · Cited by 5
The Art of Psychoneuroimmunology in Menopause Management
Anurogo, D. (2023) · Journal of Biomedical Research & Environmental Sciences · doi:10.37871/jbres1758 · Cited by 3
Mocanu, C. S., Niculaua, M., Zbancioc, G. N., Mangalagiu, V., & Drochioiu, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052857 · Cited by 4
Wang, X.-C., Wu, G., Cai, H., Chu, C.-L., Liu, Y., Li, H.-C., Zheng, J. G., Chen, H., Lin, H., Li, S., et al. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04515-7 · Cited by 3
Gerasimov, E., Berg, M., Bolshakova, A. V., Борисович, Б. И., & Власова, О. Л. (2025) · Neural Plasticity · doi:10.1155/np/9880933 · Cited by 3
A, P., Sivaperuman, A., Natarajan, R., Nagarajan, N. C., Nachiappan, D. M., & Solomon, V. R. (2026) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2025.100260 · Cited by 3
Wu, L., Hou, F., Wang, Z., Wu, M., Wang, X., Cao, J., Wang, Y., & Cai, H. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115686 · Cited by 4
Ohara, T., Taki, Y., & Yamamoto, S. (2026) · Brain Sciences · doi:10.3390/brainsci16020242 · Cited by 3
Chen, P., Liu, T., Wei, Y., Ma, Z., Lu, T., Lan, S., Xie, J., & Mo, S. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1417186 · Cited by 3
BACE1 inhibitory potential: screening of medicinal plants collected from Nepal high altitude regions
Pandey, B. P., Oh, J., Shin, W., Subedi, A., Dahal, A., Bhattarai, S., & Kim, H. (2024) · Applied Biological Chemistry · doi:10.1186/s13765-024-00974-8 · Cited by 3
Yang, W., Yu, Q., Wang, N., Lam, K. K. Y., Lin, Z., & Xian, Y. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-025-08860-2 · Cited by 4
Yoon, S. M., Lee, Y.-W., Kim, M. J., Shin, J.-Y., Bae, G. W., & Park, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136030 · Cited by 3
Ying, C., He, Y., Guo, Y., Fan, F., Wang, B., Gao, J., Li, Y., & Zhang, Y. (2025) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x25500624 · Cited by 4
Fomin, A. S., & Sergeeva, S. P. (2023) · Problems of Geroscience · doi:10.37586/2949-4745-2-2023-80-87 · Cited by 3
Curtis, L., & Piggins, H. D. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16443 · Cited by 3
Yang, Y., Guan, P.-P., & Wang, P. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117223 · Cited by 4
Zyuz’kov, G. N., Miroshnichenko, L. А., Polyakova, T. Y., Simanina, E. V., Chaykovskyi, A. V., Vi, A., & Вадимович, Ж. В. (2024) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-024-06258-x · Cited by 3
Wu, Y., Zhan, Y., Zhu, W., & Pei, J. (2025) · Medicine · doi:10.1097/md.0000000000042651 · Cited by 2
Application of nanomaterials in central nervous system disorders
Deng, Y., Feng, Y., Ye, B., Hu, L., Qi, L., Wang, C., Zhou, C., Liu, G., Gao, X., Lin, C., et al. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06862-3 · Cited by 2
The effects of Honokiol on the liver of Alzheimer's disease mice by upregulating SIRT3
Wang, H., Liu, J., Tian, Y., Zhu, F., & Li, H. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251362185 · Cited by 4
Atractylenolide III alleviates amyloid-β-induced cognitive impairments in mice
Yuan, H., Xia, L., Li, J., Dai, C., Li, X., Xu, B., Xue, M., Shi, X., Wu, B., Dong, Z., et al. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10893-6 · Cited by 2
CD38 connects the heart and brain
Tao, Y., Duan, J., Huang, K., Wang, R., Feng, Q., Yang, C., Zhang, X., & Yang, L. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03597-9 · Cited by 2
Mathew, J., Maroky, A. S., SINDURAJ, S., & Chandrababu, A. (2025) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2025v17i5.54564 · Cited by 3
Li, M., An, C., Wang, X., Ren, M., Liu, S., Chen, R., Guo, Y., Wang, J., Fei, Y., Ma, D., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1724739 · Cited by 2
Ge, L., Sun, H., Zhang, J., Xu, L., Ma, L., & Jin, Z. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1733469 · Cited by 2
Zhong, J., He, X., Yang, H., Zhang, J., Liu, J., Yang, J., & Dong, X. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119320 · Cited by 2
Yin, J., Tuo, C.-M., Yu, K.-Y., Hu, X.-H., Fan, Y., & Wu, M. (2023) · NeuroMolecular Medicine · doi:10.1007/s12017-023-08767-w · Cited by 2
Cimiotti, C. G. V., Paganetti, P., Rossi, S., Soldini, E., & Sacco, L. (2023) · NeuroSci · doi:10.3390/neurosci4040026 · Cited by 3
Genetic and molecular basis of neurodegenerative diseases
Yogi, S., Sangeeth, A., Chimata, A. V., Padma, R., & Singh, A. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23826-0.00002-7 · Cited by 2
Xu, Y., Wei, H., Du, R., Wang, R., Zhu, Y., Zhao, T., Zhu, X., & Li, Y. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00635-y · Cited by 2
Rodríguez‐Casado, A., Álvarez, M., Merino, J. J., Tolédano, A., & Tolédano, A. (2025) · Current Alzheimer Research · doi:10.2174/0115672050375461250325074826 · Cited by 3
Alzheimer’s Disease: A Molecular Model and Implied Path to Improved Therapy
Weaver-Rosen, M., & Serwer, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063479 · Cited by 2
Therapeutic approaches in proteinopathies
Nabi‐Afjadi, M., Dabirmanesh, B., & Uversky, V. N. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.03.008 · Cited by 2
Some Advanced Biomarkers of Neurodegenerative Disorders: Focus on Cystatin C
Короленко, Т. А., Pupyshev, A. B., Беличенко, В. М., Tikhonova, M. A., & Amstislavskaya, T. G. (2023) · Neurochemical Journal · doi:10.1134/s1819712423040128 · Cited by 1
Pont, C., Sampietro, A., Pérez-Areales, F. J., Cristiano, N., Albalat, A., Pérez, B., Bartolini, M., Simone, A. D., Andrisano, V., Barenys, M., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16080982 · Cited by 1
Saccharomyces boulardii Ameliorates LPS-Induced Amyloidogenesis in Rats
Mohammadi, G., Babaei, F., Golpour, F., Rashidi, F. S., Ghafghazi, S., Dargahi, L., & Nassiri‐Asl, M. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10445-7 · Cited by 3
The Role of the Progesterone Receptor Family in Alzheimer’s Disease
Zhu, T., & Hua, F. (2025) · Biocell · doi:10.32604/biocell.2025.064879 · Cited by 1
Peyvand, P., Allami, P., & Rezaei, N. (2025) · Reviews in the Neurosciences · doi:10.1515/revneuro-2025-0025 · Cited by 1
Manna, S. L., Florio, D., Platts, J. A., Gabano, E., Ravera, M., & Marasco, D. (2025) · Dalton Transactions · doi:10.1039/d5dt00691k · Cited by 2
The efficacy and pharmacological mechanism of Guilingji to prevent Alzheimer’s disease
Hu, F., Lei, Y., Han, R., Yang, B., Liang, Y., Luan, J., Zhang, B., Wang, S., & Gou, X. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01790-y · Cited by 1
Chen, W., Huang, Q.-Y., Sun, J.-H., Yang, X., Pei, H., Cao, Y., Li, H., & Ma, L. (2025) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2025.2539987 · Cited by 1
Agarwal, U., Paliwal, S., Yadav, V., Pannu, A. S., Tonk, R. K., & Verma, S. K. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273402657250905055635 · Cited by 2
From Lesion to Decision: AI for ARIA Detection and Predictive Imaging in Alzheimer’s Disease
Christodoulou, R. C., Papageorgiou, P. S., Sarquis, M. D., Rivera, L., Gonzalez, C. M., Eller, D. W., Rivera, G., Petrou, V., Vamvouras, G., Vassiliou, E. K., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13112739 · Cited by 2
Foukarakis, I., Androni, X., Sampatakakis, S. N., Mamalaki, E., Ntanasi, E., Yannakoulia, M., Chatzipanagiotou, S., Papandreou, C., Kyrozis, A., Tsapanou, A., et al. (2025) · Sleep Medicine · doi:10.1016/j.sleep.2025.108691 · Cited by 1
Chen, J., Tian, Y., Wang, L., Zhang, Z., Jin, Q., & Xiao, B. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110789 · Cited by 2
Heme as activator and target for artemisinin: Towards multiple pharmacological bioactivity
Zhu, P., Sun, X., Fang, Y., Li, Y., & Guo, L. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102398 · Cited by 1
Chronobiology and Neurodegeneration: The Role of Melatonin in Alzheimer's Disease
Vaja, R., Vohra, M., Ramachandran, A. V., & Baxi, D. B. (2025) · Nutritional Psychiatry · doi:10.1016/j.nupsyc.2025.100001 · Cited by 1
Zyuz’kov, G. N., Miroshnichenko, L. A., Kotlovskaya, L. Y., & Chaikovskii, A. V. (2026) · Indian Journal of Physiology and Pharmacology · doi:10.25259/ijpp_291_2023 · Cited by 1
Thongdechsri, S., Kamonnat, C., Sanguanphun, T., Kraokaew, P., Jattujan, P., Niamnont, N., Smith, S. J., Cummins, S. F., Jongkamonwiwat, N., Sobhon, P., et al. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108427 · Cited by 2
Zhang, L., Zhou, X., Wu, J., Wang, H., Zhang, A., Shen, R., Yang, A., & Kou, X. (2026) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2026.145940 · Cited by 1
Nabi, S. U., Rasool, I., Khan, A., Haq, A. U., Hussain, I., Khan, M. S., Majid, S., Rashid, S., Rashid, S. M., Sehar, N., et al. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-025-01781-w · Cited by 1
Mechanisms and Therapeutic Targeting of the Gut Microbiota-Immune-Brain Axis in Alzheimer’s Disease
Wang, S., Yuan, X., Wang, T., Yang, M., Dong, P., & Han, H. (2026) · Immunological Investigations · doi:10.1080/08820139.2026.2669375 · Cited by 1
Upadhyay, R., Kar, S., & Sevanan, M. (2026) · Frontiers in Chemical Biology · doi:10.3389/fchbi.2026.1836070 · Cited by 1
Advances in the treatment of Alzheimer’s disease
Goceroglu, R. T., & Hacımüftüoğlu, A. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1819165 · Cited by 1
Large amyloid plaques associate with early behavioral alterations in 6-month-old APPswe/PS1dE9 mice
Sitdikova, K., Tsoy, A., Chaprov, K., de Munter, J., Svirin, E. P., Torosyan, H., Yenkoyan, K. B., Askarova, S., Steinbusch, H. W. M., Anthony, D. C., et al. (2026) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlag078 · Cited by 1
Bellver‐Sanchís, A., Ralchev, N., Romanska, P. R., Dyakova, N. K., Ivanova, K. I., Griñán‐Ferré, C., & Marchev, A. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177833 · Cited by 1
Lysikova, E. A., Sitdikova, K., Makhambetova, A., Chaprov, K., Вячеславовна, Г. А., Kostin, A., Novikova, P. M., Lyundup, A., Askarova, S., Kukharsky, M. S., et al. (2026) · Cells · doi:10.3390/cells15171598 · Cited by 2
ELEMENTARY PATHOPHYSIOLOGY, TREATMENT, RISK FACTOR OF ALZHEIMER’S DISEASE
(2022) · International Research Journal of Modernization in Engineering Technology and Science · doi:10.56726/irjmets30873 · Cited by 2
Scientific Evidence of Baduanjin Improving Cognitive Function in Patients with Cognitive Impairment
唐, 琼. (2024) · Open Journal of Natural Science · doi:10.12677/ojns.2024.122032 · Cited by 1
Voukali, E., Divín, D., Gómez-Samblás, M., Veetil, N. K., Krajzingrová, T., Těšičký, M., Li, T., Melepat, B., Talacko, P., & Vinkler, M. (2024) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2024.105213 · Cited by 1
Kashif, S., Feroze, S. A., & Sethi, A. A. (2024) · International Journal of Biology and Chemistry · doi:10.26577/ijbch2024v17i1-a15 · Cited by 1
Iwaya, N., Sakudo, A., Kanda, T., Furusaki, K., Onishi, R., Onodera, T., & Yoshikawa, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312761 · Cited by 1
Leite, J. R. S., de Medeiros, A. B. M., Diniz, L. A. S., Lima, C. S., de Oliveira, L. N. L., Jesus, N. A. D. S., Leonel, J. S., Quaresma, L. D. J. V., Costa, J., Benício, J. A., et al. (2025) · Caderno Pedagógico · doi:10.54033/cadpedv22n1-038 · Cited by 1
Zafarjafarzadeh, N., Feridouni, E., Sobhani-Moghaddam, S., Amini, J., Mollazadeh, S., Ataei, R., Ghomi, H. T., Beyer, C., & Sanadgol, N. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.04.002 · Cited by 1
Petrushanko, I. Y., Lisitskii, D. R., Filonov, F. A., Leonova, O. G., Mitkevich, V. A., Strelkova, M. A., & Makarov, A. А. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1665715 · Cited by 1
Xiong, L., & Wang, Z. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137159 · Cited by 1
Wei, R., He, J., Chen, W., & Tam, K. Y. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137166 · Cited by 2
Role of Phages in Past Molecular Biology and Potentially in Future Biomedicine
Serwer, P. (2025) · Encyclopedia · doi:10.3390/encyclopedia5020058 · Cited by 1
Arterial Hypertension and Cognitive Disorders: What are the Risks?
Bourin, M. (2023) · SAR Journal of Psychiatry and Neuroscience · doi:10.36346/sarjpn.2023.v04i03.002
Rodrigues, A. R., Silva, D. G., OLIVEIRA, J. A. D., Costa, N. S. C. P., Moura, O. S. D. B., Rebouças, R. C. C. P., & Ferreira, R. R. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n3-382
Toward a Dimension-Free, Pre-Emptive, Integrated Health Risk Assessment of Chemicals
Ishido, M. (2023) · Springer eBooks · doi:10.1007/978-981-99-1560-6_13
温, 涛. (2023) · Medical Diagnosis · doi:10.12677/md.2023.134067
Glycosphingolipids and central nervous system–related diseases
Guo, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16156-8.00007-9
Shakir, Z. A., Sana, M., Aziz, O., Yasin, A., Khaliq, H. M. H., Saeed, Z. H., & Shahzad, N. (2024) · Journal of Health and Rehabilitation Research · doi:10.61919/jhrr.v4i1.582
Nahid, Z. B. S., Ahmed, F., Ahammed, T., Uddin, M. K., Islam, M. S., Sajib, S. M. M. H., & Islam, M. R. (2024) · Advances in Alzheimer s Disease · doi:10.4236/aad.2024.131001
Orellana, G. E., & Haglund, E. (2024) · ACS in focus · doi:10.1021/acsinfocus.7e7032
Nangdev, P., Bughio, R., Rathi, N., & Devi, D. (2024) · Journal of Health and Rehabilitation Research · doi:10.61919/jhrr.v4i2.769
Some Advanced Biomarkers of Neurodegenerative Disorders: Focus on Cystatin C
Короленко, Т. А., Pupyshev, A. B., Беличенко, В. М., Tikhonova, M. A., & Amstislavskaya, T. G. (2023) · Нейрохимия · doi:10.31857/s102781332304012x
Recent Advances on Early Diagnosis and Immunotherapy Drug for Alzheimer's Disease
Cui, X., & Lin, H. L. (2024) · MEDS Basic Medicine · doi:10.23977/medbm.2024.020117
Cao, F., Xu, L., He, X., Chi, Y., Wang, Y., Zhang, D., & Liu, Q. (2024) · Archives of Medical Science · doi:10.5114/aoms/189906
Alzheimer's Disease and the Amyloid Cascade
Oliveira, I. C., Castro, M. D. M. E., CONSULIN, V., Antunes, G. H., dos Santos, T. A., Lourenço, J. P. V., Covizzi, I. V. B., Vayego, S. A., Lima, A. R. D. A., & Covizzi, U. D. S. (2024) · Seven Editora eBooks · doi:10.56238/sevened2024.016-023
O USO DAS PROTEÍNAS ΒETA-AMILOIDE E TAU COMO NOVA ABORDAGEM TERAPÊUTICA NA DOENÇA DO ALZHEIMER
Pimentel, A. P. A., Rosas, B. D. P. S., Parente, C. T. C., & Rezende, G. D. O. (2024) · Revista Contemporânea · doi:10.56083/rcv4n10-192 · Cited by 24
A Review of Electron Microscopy Studies of the Brain in Schizophrenia
Brown, J. S. (2024) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-3065-4.ch003
Mackie, E. C., Cheng, C.-H., Alibrio, M. N., Rutledge, C., Xin, H., Chopp, M., McCann, R., Rosene, D. L., Yang, Q., Zeldich, E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.14.623673
Prospects for applying the chronic social conflict model in medical and biological research
Kudryavtseva, N. N. (2024) · Успехи физиологических наук · doi:10.31857/s0301179824040027
Could Blood Transfusion Increase the Risk of Alzheimer’s Disease? A Narrative Review
Li, X., Pei, R., Fei, Z., Chen, Z., Lin, F., Sun, P., & Cao, H. (2025) · Healthcare · doi:10.3390/healthcare13050452
Mashhadi-Sharif, N., Soodi, M., Mirnajafi‐Zadeh, J., Shadboorestan, A., Ebadi-Ramsheh, H., & Bakhtiarzadeh, F. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04365-3
Epigenetic modulation of human neurobiological disorders: Lesch-Nyhan disease as a model disorder
Nguyen, K. V. (2025) · AIMS neuroscience · doi:10.3934/neuroscience.2025005
The potential utility of arterial spin labeling in predicting brain amyloidosis
Kazemzadeh, K., Naseri, N., Mombeini, M., Khodadadi, A., Jafari, M., Rostami, R., Enayat, P., Sadeghi, M., Berenjian, S., & Alavi, S. M. A. (2025) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2025.111248
Vogels, L., Mohammadi, R., Schoonhoven, M., Birbil, Ş. İ., Dyrba, M., & Initiative, A. D. N. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251337944 · Cited by 2
Overview of Bioactive Compounds for Neurodegenerative Disorders
Tripathi, S. M., Mishra, S. K., Malviya, R., & Ojha, S. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815324846125010003
Hosseini, S. F., Akbarabadi, P., Noorani, F., Kazemi, D., Sadeghsalehi, H., Fattahpour, M., Sheybani‐Arani, M., Noroozi, M., Kazemi, A., & Initiative, A. D. N. (2025) · Current Alzheimer Research · doi:10.2174/0115672050379856250529113023
Takeuti, F. Y., Paltanin, A. V. F., Molina, C. J. F., & Santos, A. D. L. (2025) · Revista de Pesquisa Cuidado é Fundamental Online · doi:10.9789/2175-5361.rpcfo.v17.13779
The Role of T Cells in Alzheimer's Disease
Lin, Y., Zhao, H., Meng, D., & Wang, M. (2025) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2025061107
Bay leaves: the neuroprotective dietary spice via inhibition of amyloid-like aggregation
Mustafa, N., Khan, S. I., Anwar, L., Uzairullah, M. M., Bhatti, H. A., Ali, S. A., & Abbas, G. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01677-9
Helicobacter hepaticus CdtB promoted brain impairment in BALB/c mice via gut-brain axis
Zhang, Y., Yang, L., Wang, Y., Yin, J., Wang, T., Zhu, L., & Zhang, Q. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00745-w
Metadata
- Authors
- Ma, C., Hong, F., & Yang, S.
- Affiliations
- Nanchang University (CN)
- Experimental Center of Pathogen Biology, Nanchang University, Nanchang 330006, China
- Department of Physiology, College of Medicine, Nanchang University, Nanchang 330006, China
- ORCID
- Ma, Chen
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2022-02-11
- Volume
- 27
- Issue
- 4
- Pages
- 1210
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC8876037
- OpenAlex
- W4212889165
- Cited by
- 243
- References
- 83
- Citations by year
- 2026: 51 · 2025: 80 · 2024: 65 · 2023: 36 · 2022: 11
- FWCI
- 6.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- the National Natural Science Foundation of China (82060661,81660151 and 81660751)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloidosis, amyloid hypothesis, amyloid-beta, amyloid precursor protein, amyloid fibril formation, autophagy, cerebral blood flow, acetylcholinesterase, LRP1, oxidative damage, tau protein, neurofibrillary tangles, neuronal injury, Alzheimer's disease treatment
- MeSH terms
- Alzheimer Disease, Amyloid, Amyloidosis, Animals, Autophagy, Brain, Disease Susceptibility, Gene Expression Regulation, Humans, Risk Factors, Biomarkers, Amyloid beta-Peptides, Disease Management, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
